These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8735987)

  • 1. H-Lys-Arg-Asn-Lys-Asn-Asn-OH is the minimal active structure of oxyntomodulin.
    Carles-Bonnet C; Martinez J; Jarrousse C; Aumelas A; Niel H; Bataille D
    Peptides; 1996; 17(3):557-61. PubMed ID: 8735987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyl oxyntomodulin30-37: pharmacokinetics and activity on gastric acid secretion.
    Carles-Bonnet C; Jarrousse C; Niel H; Martinez J; Rolland M; Bataille D
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):57-63. PubMed ID: 1538791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxyntomodulin and its (19-37) and (30-37) fragments inhibit histamine-stimulated gastric acid secretion in the conscious rat.
    Carles-Bonnet C; Jarrousse C; Niel H; Martinez J; Bataille D
    Eur J Pharmacol; 1991 Oct; 203(2):245-52. PubMed ID: 1800120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of gastric acid secretion by oxyntomodulin and its 19-37 fragment in the conscious rat.
    Jarrousse C; Carles-Bonnet C; Niel H; Sabatier R; Audousset-Puech MP; Blache P; Kervran A; Martinez J; Bataille D
    Am J Physiol; 1993 May; 264(5 Pt 1):G816-23. PubMed ID: 8498507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of the C-terminal octapeptide of pig oxyntomodulin. Lys-Arg-Asn-Lys-Asn-Asn-Ile-Ala: a potent inhibitor of pentagastrin-induced acid secretion.
    Audousset-Puech MP; Jarrousse C; Dubrasquet M; Aumelas A; Castro B; Bataille D; Martinez J
    J Med Chem; 1985 Oct; 28(10):1529-33. PubMed ID: 4045927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of oxyntomodulin on gastric acid secretion induced by histamine or a meal in the rat.
    Jarrousse C; Carles-Bonnet C; Niel H; Bataille D
    Peptides; 1994; 15(8):1415-20. PubMed ID: 7700845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretion.
    Jarrousse C; Audousset-Puech MP; Dubrasquet M; Niel H; Martinez J; Bataille D
    FEBS Lett; 1985 Aug; 188(1):81-4. PubMed ID: 4018272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin enhances the inhibitory effect of oxyntomodulin and its C-terminal octapeptide on acid secretion.
    Dubrasquet JM; Audousset-Puech MP; Martinez J; Bataille D
    Peptides; 1986; 7 Suppl 1():257-9. PubMed ID: 2875447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxyntomodulin and its C-terminal octapeptide inhibit liquid meal-stimulated acid secretion.
    Jarrousse C; Niel H; Audousset-Puech MP; Martinez J; Bataille D
    Peptides; 1986; 7 Suppl 1():253-6. PubMed ID: 3748850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of the C-terminal octapeptide of oxyntomodulin on pentagastrin-stimulated gastric acid secretion in man.
    Veyrac M; Ribard D; Daures JP; Mion H; Lequellec A; Martinez J; Bataille D; Michel H
    Scand J Gastroenterol; 1989 Dec; 24(10):1238-42. PubMed ID: 2690315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities.
    Bataille D; Gespach C; Tatemoto K; Marie JC; Coudray AM; Rosselin G; Mutt V
    Peptides; 1981; 2 Suppl 2():41-4. PubMed ID: 6283496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gastric acid secretagogue gastrin-releasing peptide and the inhibitor oxyntomodulin do not exert their effect directly on the parietal cell in the rat.
    Gehl J; Jeppesen JL; Poulsen SS; Holst JJ
    Digestion; 1988; 40(3):144-51. PubMed ID: 3234620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats.
    Dubrasquet M; Bataille D; Gespach C
    Biosci Rep; 1982 Jun; 2(6):391-5. PubMed ID: 6125221
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of oxyntomodulin (glucagon-37) and glucagon on exocrine pancreatic secretion in the conscious rat.
    Biedzinski TM; Bataille D; Devaux MA; Sarles H
    Peptides; 1987; 8(6):967-72. PubMed ID: 3441447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man.
    Schjoldager BT; Baldissera FG; Mortensen PE; Holst JJ; Christiansen J
    Eur J Clin Invest; 1988 Oct; 18(5):499-503. PubMed ID: 3147901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2.
    Schepp W; Dehne K; Riedel T; Schmidtler J; Schaffer K; Classen M
    Digestion; 1996; 57(6):398-405. PubMed ID: 8913701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and sequence of rat oxyntomodulin.
    Collie NL; Walsh JH; Wong HC; Shively JE; Davis MT; Lee TD; Reeve JR
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9362-6. PubMed ID: 7937770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biological significance of "enteroglucagon." Present status.
    Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
    Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effect of glucagon-like peptide-1 (7-36)amide, oxyntomodulin, vasoactive intestinal peptide and somatostatin on gastric acid and pepsinogen secretion.
    Ben-Hamida A; Houssein AA; Man WK; Spencer J
    Inflamm Res; 1997 Mar; 46 Suppl 1():S105-6. PubMed ID: 9098788
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurotensin and oxyntomodulin-(30-37) potentiate PYY regulation of gastric acid and somatostatin secretions.
    Bado A; Cloarec D; Moizo L; Laigneau JP; Bataille D; Lewin MJ
    Am J Physiol; 1993 Jul; 265(1 Pt 1):G113-7. PubMed ID: 8101697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.